Detalles de la búsqueda
1.
Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
Eur Arch Psychiatry Clin Neurosci;
273(7): 1463-1476, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890259
2.
Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling.
Int J Mol Sci;
23(20)2022 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36293063
3.
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases.
J Clin Psychopharmacol;
42(5): 503-506, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35943402
4.
Childhood Clinical Features Preceding the Onset of Bipolar Versus Major Depressive Disorders During Adolescence.
J Atten Disord;
28(5): 648-663, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38327097
5.
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive Disorder.
Prim Care Companion CNS Disord;
25(1)2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36821775
6.
Urgent Psychiatric Consultations for Suicidal Ideation and Behaviors in Italian Adolescents during Different COVID-19 Pandemic Phases.
J Pers Med;
13(7)2023 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511725
7.
Eye Movement Desensitization and Reprocessing (EMDR) as a Possible Evidence-Based Rehabilitation Treatment Option for a Patient with ADHD and History of Adverse Childhood Experiences: A Case Report Study.
J Pers Med;
13(2)2023 Jan 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36836434
8.
Urgent psychiatric consultations for suicide attempt and suicidal ideation before and after the COVID-19 pandemic in an Italian pediatric emergency setting.
Front Psychiatry;
14: 1135218, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37457771
9.
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism.
Drugs R D;
2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010591
10.
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
Transl Psychiatry;
13(1): 192, 2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286536
11.
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial.
Am J Psychiatry;
179(2): 122-131, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34933568
Resultados
1 -
11
de 11
1
Próxima >
>>